Comparative evaluation of olopatadine 0.01% combined fluorometholone 0.1% treatment versus olopatadine 0.01% combined ketorolac 0.4% treatment in patients with acute seasonal allergic conjunctivitis.
Current eye research, vol.39, no.1, pp.42-6, 2014 (SCI-Expanded, Scopus)
- Publication Type: Article / Article
- Volume: 39 Issue: 1
- Publication Date: 2014
- Doi Number: 10.3109/02713683.2013.827213
- Journal Name: Current eye research
- Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
- Page Numbers: pp.42-6
- Keywords: Fluorometholone, ketorolac, seasonal allergic conjunctivitis, LOTEPREDNOL ETABONATE, OPHTHALMIC SOLUTION, OCULAR ALLERGY, EFFICACY, HYDROCHLORIDE, 0.2-PERCENT, SUSPENSION, COMFORT, SODIUM, DRUGS
- Akdeniz University Affiliated: Yes
Abstract
Purpose: To evaluate the therapeutic effects of low-effective steroid fluorometholone 0.1% and non-steroidal anti-inflammatory ketorolac 0.4% when concomitantly used with olopatadine 0.01% in relieving clinical signs and symptoms of acute seasonal allergic conjunctivitis (SAC).